Cognitive disorders expert joins Nantz National Alzheimer Center in HoustonHouston, TX - 5/9/2012
Bryan M. Spann, D.O., Ph.D., adds clinical leadership to Methodist’s Alzheimer’s program
Bryan M. Spann, D.O., Ph.D., a board-certified neurologist specializing in the clinical management of patients with cognitive disorders, has been named clinic director of the Methodist Neurological Institute’s Nantz National Alzheimer Center.
Spann most recently served as medical director of the Memory and Aging Center at the University of Southern California. As clinic director at Methodist, Spann joins a multidisciplinary team led by Dr. Gustavo C. Roman, director of the Nantz National Alzheimer Center. The team’s focus covers the spectrum of cognitive disorders and dementias.
“As clinical director my goal is to provide comprehensive care and assistance to both the patient and family,” Spann said. “Through the Nantz National Alzheimer Center, every patient will benefit from state of the art neurological diagnosis, treatment and management of various disorders which can result in either cognitive impairment or dementia.”
While Spann’s clinical role is to provide neurological care, patients will also have access through the center to social work services, gerontology and neuropsychology.
Spann received his Ph.D. and D.O. at Michigan State University. He completed his residency at Cleveland Clinic followed by fellowship training in both movement and neurobehavioral disorders. Spann’s clinical interest includes mild cognitive disorders, Alzheimer disease and dementia with movement disorders. In addition, Spann is interested in non-cognitive manifestations of dementia such as behavioral changes and sleep disorders.
The center’s rapidly growing faculty includes recent hire Belen Pascual, Ph.D, formerly of Massachusetts General Hospital and Harvard Medical School. Pascual’s role at the Nantz National Alzheimer Center is to enhance research efforts into the neurobiological aspects of cognition, while using neuropsychological and imaging tools to foster the discovery of more effective treatments for Alzheimer disease and related disorders.
Gale Smith on Twitter: @gsmithmethodist